- Patients don’t regain much weight switching from injections to Lilly’s weight-loss pill, study finds Reuters
- Daily pill can help people maintain weight loss after they come off jabs, trial shows The Guardian
- Lilly’s Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials investor.lilly.com
- Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial Nature
- Daily weight-loss pills could spell end of type 2 diabetes The Times
- Quitting weight-loss drugs or a diet can cause weight regain—two strategies could help prevent that Scientific American
- Oral GLP-1 medication helps patients maintain weight loss Cornell Chronicle
- Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies Fierce Pharma
- Popular weight loss and anti-inflammatory drugs may help prevent common heart rhythm disorder Medical Xpress
Brought to you by Google News. Read the rest of the article here